Cullinan Therapeutics CGEM
NASDAQ CGEM
$15.04 +0.15 (+1.01%)
As of: Oct 22, 2026 · 9:45 AM EDT

Cullinan Therapeutics (CGEM) Asset Utilization Ratio (2021)

Updated

Cullinan Therapeutics' (CGEM) Asset Utilization Ratio came in at 0.04 for Q4 2021.

Analysis

Cullinan Therapeutics (CGEM) Asset Utilization Ratio (2021) Analysis & Trends

For FY2021, Cullinan Therapeutics' Asset Utilization Ratio stood at 0.06.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,155.80 Bn 1,124.39 Bn 19.71 Bn 0.62
2 Johnson & Johnson 630.65 Bn 549.18 Bn 17.26 Bn 0.49
3 AbbVie 502.74 Bn 475.85 Bn 12.70 Bn 0.47
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn 0.52
5 Novartis Ag 301.36 Bn 265.35 Bn 11.24 Bn 0.46
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn 0.51
7 Amgen 239.16 Bn 194.55 Bn 7.24 Bn 0.40
8 Gilead Sciences 192.63 Bn 166.82 Bn 6.22 Bn 0.58
9 Pfizer 171.82 Bn 118.47 Bn 10.94 Bn 0.31
10 Cullinan Therapeutics 932.68 Mn 598.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 0.04
API Access

Cullinan Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CGEM&period=max&api_key=YOUR_API_KEY